Document Detail

A pilot study assessing the frequency and complexity of methadone tapers for opioid abstinence syndrome in children discharged to home.
MedLine Citation:
PMID:  22222345     Owner:  NLM     Status:  Publisher    
BACKGROUND: Methadone is often prescribed as a taper schedule to prevent/treat opioid abstinence syndrome (OAS) or neonatal abstinence syndrome (NAS). OBJECTIVE: The objective of this study was to determine the percentage of children discharged home on methadone tapers and to develop, assess, and implement an instrument for measuring the complexity of the methadone regimens. METHODS: This study used a descriptive retrospective design to examine patients younger than 18 years from January 1, 2008, to December 31, 2008, administered methadone for prevention/treatment of OAS/NAS and discharged home on a methadone taper. Data collection included demographics and characteristics of methadone regimen. The primary objective was to determine the percentage of children discharged on methadone. Secondary objectives included characterization (ie, number of dosage and interval changes), duration, and complexity of the methadone taper. Descriptive statistics were performed using Stata v10 (StataCorp LP, College Station, TX). Complexity was evaluated using the medication taper complexity score (MTCS) between 4 raters. Reliability of the MTCS was established using interrater correlation analyses of the regimen complexity scores. RESULTS: Thirty-three patients (41.8%) were discharged on methadone. The median (range) age was 0.42 (0-12) years, with most patients (75.8%) initiated on methadone for prevention of OAS. Thirty-one patients were included for further analysis of medication complexity. The median (range) duration of the home taper was 8 days (2-48), which included a median (range) of 4 (1-11) dose changes and at least 1 (0-2) change in the interval. MTCS ranged from 7 to 42, with the tool demonstrating 95% interrater reliability. CONCLUSIONS: More than one-third of patients were discharged home on methadone. The median taper duration was 8 days and included a median of 5 adjustments in either the dose or interval. The MTCS demonstrated very good interrater reliability to measure wide variability in the complexity of individual tapers. Future studies should determine the construct validity of the MTCS and the applicability of this tool for further research and clinical application.
Peter N Johnson; Donald L Harrison; Christine H Castro; Jamie L Miller
Related Documents :
17200305 - Long-term results of surgery for brachial plexus birth palsy.
25165535 - The need for antibiotic stewardship and treatment standardization in the care of cirrho...
18342545 - Interposition arthroplasty of the elbow with hinged external fixation for post-traumati...
22174465 - Fibreoptic bronchoscopy without sedation: is transcricoid injection better than the "sp...
24271095 - Acute effects of transcutaneous electrical diaphragmatic stimulation on respiratory pat...
23130115 - Incremental reduction in risk of death associated with use of guideline-recommended the...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-3
Journal Detail:
Title:  Research in social & administrative pharmacy : RSAP     Volume:  -     ISSN:  1934-8150     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101231974     Medline TA:  Res Social Adm Pharm     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
Department of Pharmacy: Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy, 1110 N. Stonewall Ave., CPB 206, Oklahoma City, OK 73117, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Awareness and knowledge of autism among pharmacists.
Next Document:  U.S. publication trends in social and administrative pharmacy: Implications for promotion and tenure...